Yilin Xie

The liver-heart-lung axis in pulmonary arterial hypertension: bidirectional mechanisms, prognostic biomarkers, and clinical integration

Pulmonary arterial hypertension (PAH) is increasingly recognized as a systemic disorder. Liver involvement in PAH is common, ranging from subclinical cholestatic abnormalities and impaired synthetic function to congestive hepatopathy and cardiac cirrhosis, and these changes close...